title: Miller Fisher syndrome associated with Burkitt's lymphoma.
authors.forename: S
authors.initials: S
authors.lastname: Gentile
authors.forename: M
authors.initials: M
authors.lastname: Messina
authors.forename: I
authors.initials: I
authors.lastname: Rainero
authors.forename: R
authors.initials: R
authors.lastname: Lo Giudice
authors.forename: P
authors.initials: P
authors.lastname: De Martino
authors.forename: L
authors.initials: L
authors.lastname: Pinessi
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000150:complications* / Q000188:drug therapy; D005732:Gangliosides / Q000276:immunology; D004854:Herpesvirus 4, Human; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000150:complications*; D016030:Kidney Transplantation; D008297:Male; D019846:Miller Fisher Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010257:Paraneoplastic Syndromes / Q000503:physiopathology*; D014412:Tumor Virus Infections / Q000150:complications; D014513:Ureter / Q000002:abnormalities
chemical_list: D000970:Antineoplastic Agents; D005732:Gangliosides; D016756:Immunoglobulins, Intravenous; C039129:GQ1b ganglioside